Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Eli Lilly issues voluntary recall of lot of Glucagon Emergency Kit for Low Blood » 08:51
09/26/21
09/26
08:51
09/26/21
08:51
LLY

Eli Lilly

$231.70 /

-0.42 (-0.18%)

Eli Lilly is voluntarily…

Eli Lilly is voluntarily recalling lot D239382D, Expiration April 2022, of Glucagon Emergency Kit for Low Blood Sugar to the consumer/user level. Lilly is recalling lot D239382D to the patient level because of a product complaint reporting that the vial of Glucagon was in liquid form instead of the powder form. The company's investigation indicates that the liquid in this Glucagon vial could be related to the manufacturing process. The use of the liquid form of this product may fail to treat severe low blood sugar due to loss of potency. Risk Statement: Severe hypoglycemia in patients with diabetes, if not reversed, can potentially cause adverse health consequences ranging from transient, minor complaints to neurological damage, seizures, and even death if not promptly treated. Associated with the one product complaint, it was reported to Lilly that the involved patient experienced lack of drug effect and also reported subsequent seizures. Lilly is notifying its distributors and customers by written communication and is arranging for return and replacement of all recalled products. Wholesalers and Distributors with an existing inventory of Glucagon Emergency Kit lot D239382D should cease distribution and quarantine the product immediately.

ShowHide Related Items >><<
LLY Eli Lilly
$231.70 /

-0.42 (-0.18%)

LLY Eli Lilly
$231.70 /

-0.42 (-0.18%)

09/24/21 JPMorgan
Eli Lilly remains best positioned growth story in pharma, says JPMorgan
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
LLY Eli Lilly
$231.70 /

-0.42 (-0.18%)

LLY Eli Lilly
$231.70 /

-0.42 (-0.18%)

LLY Eli Lilly
$231.70 /

-0.42 (-0.18%)

LLY Eli Lilly
$231.70 /

-0.42 (-0.18%)

Friday
Conference/Events
UBS biotechnology analysts to hold an analyst/industry conference call » 09:54
09/24/21
09/24
09:54
09/24/21
09:54
BIIB

Biogen

$289.00 /

-4.19 (-1.43%)

, IONS

Ionis Pharmaceuticals

$37.30 /

+0.07 (+0.19%)

Biotechnology Analysts…

Biotechnology Analysts Bristow and Rajavelu discuss Biogen and Ionis Pharmaceuticals' Tofersen, an antisense oligonucleotide (ASO) therapy being evaluated for the potential treatment of SOD1-associated ALS on an Analyst/Industry conference call to be held on September 24 at 10 am. Webcast Link

ShowHide Related Items >><<
IONS Ionis Pharmaceuticals
$37.30 /

+0.07 (+0.19%)

BIIB Biogen
$289.00 /

-4.19 (-1.43%)

BIIB Biogen
$289.00 /

-4.19 (-1.43%)

09/24/21 JPMorgan
Eli Lilly remains best positioned growth story in pharma, says JPMorgan
09/23/21 Mizuho
Biogen sales reps banned by D.C. neurology practice, says Mizuho
09/23/21 Cowen
CMS director telling states Aduhelm covered, restrictions can apply, says Cowen
09/22/21 Needham
Biogen initiated with a Buy at Needham
IONS Ionis Pharmaceuticals
$37.30 /

+0.07 (+0.19%)

07/15/21 Canaccord
Bicycle Therapeutics price target raised to $40 from $36 at Canaccord
07/14/21 Benchmark
Bicycle deal 'makes little sense' for Ionis, says Benchmark
07/13/21 William Blair
Bicycle collaboration a positive for Ionis, says William Blair
07/13/21 Piper Sandler
Bicycle Therapeutics price target raised to $46 from $39 at Piper Sandler
IONS Ionis Pharmaceuticals
$37.30 /

+0.07 (+0.19%)

BIIB Biogen
$289.00 /

-4.19 (-1.43%)

BIIB Biogen
$289.00 /

-4.19 (-1.43%)

IONS Ionis Pharmaceuticals
$37.30 /

+0.07 (+0.19%)

BIIB Biogen
$289.00 /

-4.19 (-1.43%)

BIIB Biogen
$289.00 /

-4.19 (-1.43%)

Recommendations
Eli Lilly remains best positioned growth story in pharma, says JPMorgan » 07:27
09/24/21
09/24
07:27
09/24/21
07:27
LLY

Eli Lilly

$232.12 /

+3.81 (+1.67%)

, BIIB

Biogen

$293.41 /

+4.155 (+1.44%)

JPMorgan analyst Chris…

JPMorgan analyst Chris Schott says Eli Lilly remains the best positioned growth story in his coverage and one of his top picks following the stock's pullback over the past month. For donanemab, Schott continues to expect a 2022 accelerated approval for the drug and he sees Biogen's (BIIB) Aduhelm commercial struggles as having only limited read across to Lilly. Beyond Alzheimer's, the analyst sees "significant opportunity" for tirzepatide in type 2 diabetes, and obesity, which in his view "warrants increased attention in light of the strong Wegovy launch." Schott reiterates an Overweight rating on Eli Lilly with a $300 price target.

ShowHide Related Items >><<
LLY Eli Lilly
$232.12 /

+3.81 (+1.67%)

BIIB Biogen
$293.41 /

+4.155 (+1.44%)

LLY Eli Lilly
$232.12 /

+3.81 (+1.67%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
BIIB Biogen
$293.41 /

+4.155 (+1.44%)

09/23/21 Mizuho
Biogen sales reps banned by D.C. neurology practice, says Mizuho
09/23/21 Cowen
CMS director telling states Aduhelm covered, restrictions can apply, says Cowen
09/22/21 Needham
Biogen initiated with a Buy at Needham
09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
LLY Eli Lilly
$232.12 /

+3.81 (+1.67%)

BIIB Biogen
$293.41 /

+4.155 (+1.44%)

LLY Eli Lilly
$232.12 /

+3.81 (+1.67%)

BIIB Biogen
$293.41 /

+4.155 (+1.44%)

LLY Eli Lilly
$232.12 /

+3.81 (+1.67%)

BIIB Biogen
$293.41 /

+4.155 (+1.44%)

LLY Eli Lilly
$232.12 /

+3.81 (+1.67%)

BIIB Biogen
$293.41 /

+4.155 (+1.44%)

Thursday
Recommendations
Biogen sales reps banned by D.C. neurology practice, says Mizuho » 11:28
09/23/21
09/23
11:28
09/23/21
11:28
BIIB

Biogen

$296.07 /

+6.815 (+2.36%)

Mizuho analyst Salim Syed…

Mizuho analyst Salim Syed confirmed that all Biogen sales representatives, not just Aduhelm reps, have been blocked from entering The Neurology Center, a D.C.-based neurology practice with seven locations. The analyst has a Neutral rating on Biogen shares with a $300 price target.

ShowHide Related Items >><<
BIIB Biogen
$296.07 /

+6.815 (+2.36%)

BIIB Biogen
$296.07 /

+6.815 (+2.36%)

09/23/21 Cowen
CMS director telling states Aduhelm covered, restrictions can apply, says Cowen
09/22/21 Needham
Biogen initiated with a Buy at Needham
09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
09/20/21 Piper Sandler
Neurologist survey shows Aduhelm 'rebounded sharply,' says Piper Sandler
BIIB Biogen
$296.07 /

+6.815 (+2.36%)

BIIB Biogen
$296.07 /

+6.815 (+2.36%)

BIIB Biogen
$296.07 /

+6.815 (+2.36%)

BIIB Biogen
$296.07 /

+6.815 (+2.36%)

Recommendations
CMS director telling states Aduhelm covered, restrictions can apply, says Cowen » 09:42
09/23/21
09/23
09:42
09/23/21
09:42
BIIB

Biogen

$289.26 /

+ (+0.00%)

Cowen Washington Research…

Cowen Washington Research Group analyst Eric Assaraf noted that John Coster, Director of Pharmacy in CMS' Center for Medicaid & CHIP Services, said at an AHIP conference on September 22 that Biogen's Aduhelm "is currently a covered outpatient drug" and that states must cover Aduhelm under the existing participation by Biogen in the Medicaid drug rebate program, but he also noted that states can develop their own medical necessity criteria as part of their coverage policy. When pressed later on the subject, Coster reiterated the agency's position, being quoted by Assaraf as having stated: "Currently, the requirements are that if a drug is a covered outpatient drug, it has to be covered subject to a state's medical eligibility criteria." CMS initiated a National Coverage Analysis in July and has made clear that it views the Aduhelm NCA as a class-wide coverage decision that will impact all future beta amyloid Alzheimer's drugs, the note from the WRG analyst added.

ShowHide Related Items >><<
BIIB Biogen
$289.26 /

+ (+0.00%)

BIIB Biogen
$289.26 /

+ (+0.00%)

09/22/21 Needham
Biogen initiated with a Buy at Needham
09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
09/20/21 Piper Sandler
Neurologist survey shows Aduhelm 'rebounded sharply,' says Piper Sandler
09/16/21 UBS
Biogen price target lowered to $442 from $475 at UBS
BIIB Biogen
$289.26 /

+ (+0.00%)

BIIB Biogen
$289.26 /

+ (+0.00%)

BIIB Biogen
$289.26 /

+ (+0.00%)

BIIB Biogen
$289.26 /

+ (+0.00%)

Wednesday
On The Fly
Wall Street in Fives - Must Read Lists for Wednesday » 16:28
09/22/21
09/22
16:28
09/22/21
16:28
FDX

FedEx

$229.05 /

-23.04 (-9.14%)

, GILD

Gilead

$71.38 /

-0.35 (-0.49%)

, PFE

Pfizer

$43.95 /

+0.04 (+0.09%)

, BNTX

BioNTech

$339.40 /

-2.11 (-0.62%)

, HOOD

Robinhood

$46.90 /

+4.57 (+10.80%)

, XPOF

Xponential Fitness

$11.17 /

+0.875 (+8.50%)

, SOFI

SoFi Technologies

$16.84 /

+1.685 (+11.12%)

, SPWR

SunPower

$22.26 /

+1.18 (+5.60%)

, AMBA

Ambarella

$164.22 /

+15.24 (+10.23%)

, FGEN

FibroGen

$10.19 /

-1.045 (-9.31%)

, AMZN

Amazon.com

$3,380.08 /

+33.19 (+0.99%)

, AAPL

Apple

$145.80 /

+2.39 (+1.67%)

, ECIFF

EDF

$11.50 /

+ (+0.00%)

, GE

General Electric

$98.55 /

+1.68 (+1.73%)

, BIIB

Biogen

$289.26 /

-6.515 (-2.20%)

, MCD

McDonald's

$243.15 /

+2.57 (+1.07%)

, DVAX

Dynavax

$18.76 /

+3.91 (+26.33%)

, TECK

Teck Resources

$24.69 /

+1.51 (+6.51%)

, GOTU

Gaotu Techedu

$3.09 /

+0.65 (+26.64%)

, WKHS

Workhorse Group

$7.41 /

-0.78 (-9.52%)

, INCY

Incyte

$69.58 /

-6.45 (-8.48%)

, GIS

General Mills

$59.94 /

+1.925 (+3.32%)

, INNV

InnovAge

$8.81 /

-2.7 (-23.46%)

, BDSI

BioDelivery Sciences

$3.50 /

-0.52 (-12.94%)

, ADBE

Adobe

$626.47 /

-19.94 (-3.08%)

, SFIX

Stitch Fix

$41.04 /

+5.59 (+15.77%)

Get caught up quickly on…

ShowHide Related Items >><<
XPOF Xponential Fitness
$11.17 /

+0.875 (+8.50%)

WKHS Workhorse Group
$7.41 /

-0.78 (-9.52%)

TECK Teck Resources
$24.69 /

+1.51 (+6.51%)

SPWR SunPower
$22.26 /

+1.18 (+5.60%)

SOFI SoFi Technologies
$16.84 /

+1.685 (+11.12%)

SFIX Stitch Fix
$41.04 /

+5.59 (+15.77%)

PFE Pfizer
$43.95 /

+0.04 (+0.09%)

MCD McDonald's
$243.15 /

+2.57 (+1.07%)

INNV InnovAge
$8.81 /

-2.7 (-23.46%)

INCY Incyte
$69.58 /

-6.45 (-8.48%)

HOOD Robinhood
$46.90 /

+4.57 (+10.80%)

GOTU Gaotu Techedu
$3.09 /

+0.65 (+26.64%)

GIS General Mills
$59.94 /

+1.925 (+3.32%)

GILD Gilead
$71.38 /

-0.35 (-0.49%)

GE General Electric
$98.55 /

+1.68 (+1.73%)

FGEN FibroGen
$10.19 /

-1.045 (-9.31%)

FDX FedEx
$229.05 /

-23.04 (-9.14%)

DVAX Dynavax
$18.76 /

+3.91 (+26.33%)

BNTX BioNTech
$339.40 /

-2.11 (-0.62%)

BIIB Biogen
$289.26 /

-6.515 (-2.20%)

BDSI BioDelivery Sciences
$3.50 /

-0.52 (-12.94%)

AMZN Amazon.com
$3,380.08 /

+33.19 (+0.99%)

AMBA Ambarella
$164.22 /

+15.24 (+10.23%)

ADBE Adobe
$626.47 /

-19.94 (-3.08%)

AAPL Apple
$145.80 /

+2.39 (+1.67%)

FDX FedEx
$229.05 /

-23.04 (-9.14%)

09/22/21
Fly Intel: Top five analyst downgrades
09/22/21 Wells Fargo
FedEx price target lowered to $314 from $351 at Wells Fargo
09/22/21 Stephens
FedEx price target lowered to $330 from $360 at Stephens
09/22/21 KeyBanc
FedEx price target lowered to $325 from $350 at KeyBanc
GILD Gilead
$71.38 /

-0.35 (-0.49%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
PFE Pfizer
$43.95 /

+0.04 (+0.09%)

09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
BNTX BioNTech
$339.40 /

-2.11 (-0.62%)

08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
08/20/21 Canaccord
BioNTech price target raised to $450 from $240 at Canaccord
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
HOOD Robinhood
$46.90 /

+4.57 (+10.80%)

08/23/21
Fly Intel: Top five analyst initiations
08/23/21 Rosenblatt
Robinhood initiated with a Buy at Rosenblatt
08/23/21 JPMorgan
JPMorgan starts Robinhood at Underweight, says success priced into shares
08/23/21 Deutsche Bank
Deutsche starts Robinhood at Hold despite 'exceptionally attractive' potential
XPOF Xponential Fitness
$11.17 /

+0.875 (+8.50%)

09/22/21
Fly Intel: Top five analyst upgrades
09/22/21 Raymond James
Xponential Fitness double upgraded to Strong Buy at Raymond James
09/22/21 Raymond James
Xponential Fitness upgraded to Strong Buy from Market Perform at Raymond James
08/17/21 Guggenheim
Xponential Fitness initiated with Buy, $16 target at Guggenheim
SOFI SoFi Technologies
$16.84 /

+1.685 (+11.12%)

09/22/21
Fly Intel: Top five analyst initiations
09/22/21 Jefferies
SoFi Technologies initiated with a Buy at Jefferies
09/14/21 Mizuho
Mizuho starts SoFi with Buy amid 'powerful transition' to 'neo-bank'
09/14/21 Mizuho
SoFi Technologies initiated with a Buy at Mizuho
SPWR SunPower
$22.26 /

+1.18 (+5.60%)

09/22/21 Evercore ISI
Evercore starts SunPower at Outperform, sees 26% upside potential
09/22/21 Evercore ISI
SunPower initiated with an Outperform at Evercore ISI
07/15/21 Piper Sandler
SunPower price target lowered to $26 from $28 at Piper Sandler
AMBA Ambarella
$164.22 /

+15.24 (+10.23%)

09/22/21 KeyBanc
Ambarella upgraded to Overweight from Sector Weight at KeyBanc
09/02/21 Roth Capital
Ambarella price target raised to $170 from $130 at Roth Capital
09/01/21 Cowen
Ambarella price target raised to $150 from $140 at Cowen
FGEN FibroGen
$10.19 /

-1.045 (-9.31%)

09/22/21 Goldman Sachs
FibroGen downgraded to Sell from Neutral at Goldman Sachs
08/20/21 Raymond James
FibroGen upgraded to Market Perform from Underperform at Raymond James
08/20/21 Raymond James
FibroGen upgraded to Market Perform from Underperform at Raymond James
AMZN Amazon.com
$3,380.08 /

+33.19 (+0.99%)

09/14/21 Evercore ISI
Amazon price target raised to $4,700 from $4,200 at Evercore ISI
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Goldman Sachs
Amazon.com initiated with a Buy at Goldman Sachs
09/10/21 BofA
Affirm price target raised to $119 from $82 at BofA
AAPL Apple
$145.80 /

+2.39 (+1.67%)

09/22/21 BMO Capital
Facebook guidance unchanged, not much new on technical side, says BMO Capital
09/22/21 Tigress Financial
Apple price target raised to $198 from $182 at Tigress Financial
09/21/21 BofA
BofA says nationalist sentiment resurgence in China could hurt iPhone sales
09/21/21 Credit Suisse
Apple iPhone 13 initial waits extended versus 12 cycle, says Credit Suisse
ECIFF EDF
$11.50 /

+ (+0.00%)

GE General Electric
$98.55 /

+1.68 (+1.73%)

09/03/21 JPMorgan
Los Angeles vote shows 'secular decline' risk of GE Power, says JPMorgan
08/11/21 Citi
GE price target adjusted to $136 at Citi to account for reverse split
08/11/21 JPMorgan
GE industrial FCF a 'construct' that is 'detached from reality,' says JPMorgan
07/14/21 Deutsche Bank
General Electric price target lowered to $14 from $15 at Deutsche Bank
BIIB Biogen
$289.26 /

-6.515 (-2.20%)

09/22/21 Needham
Biogen initiated with a Buy at Needham
09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
09/20/21 Piper Sandler
Neurologist survey shows Aduhelm 'rebounded sharply,' says Piper Sandler
09/16/21 UBS
Biogen price target lowered to $442 from $475 at UBS
MCD McDonald's
$243.15 /

+2.57 (+1.07%)

07/29/21 RBC Capital
McDonald's price target raised to $268 from $263 at RBC Capital
07/29/21 Truist
McDonald's price target raised to $266 from $255 at Truist
07/29/21 Wedbush
McDonald's price target raised to $270 from $265 at Wedbush
07/29/21 Stephens
McDonald's price target raised to $260 from $245 at Stephens
DVAX Dynavax
$18.76 /

+3.91 (+26.33%)

08/31/21 H.C. Wainwright
Dynavax price target raised to $23 from $20 at H.C. Wainwright
08/05/21 Goldman Sachs
Dynavax initiated with a Buy at Goldman Sachs
08/05/21 H.C. Wainwright
Dynavax price target raised to $20 from $16 at H.C. Wainwright
02/08/21 Evercore ISI
Dynavax had 'big vaccine update week,' says Evercore ISI
TECK Teck Resources
$24.69 /

+1.51 (+6.51%)

09/22/21 Canaccord
Teck Resources price target raised to C$31 from C$28 at Canaccord
09/22/21 CIBC
Teck Resources price target raised to C$35.50 from C$34 at CIBC
09/22/21 Raymond James
Teck Resources price target raised to C$39 from C$37 at Raymond James
09/22/21 Scotiabank
Teck Resources price target lowered to C$3.21 from C$3.35 at Scotiabank
GOTU Gaotu Techedu
$3.09 /

+0.65 (+26.64%)

07/27/21 Deutsche Bank
Gaotu Techedu price target lowered to $3 from $97 at Deutsche Bank
07/26/21 CLSA
Gaotu Techedu downgraded to Sell from Underperform at CLSA
07/25/21 Goldman Sachs
Gaotu Techedu downgraded to Sell from Neutral at Goldman Sachs
07/23/21 JPMorgan
JPMorgan downgrades China education stock trio on 'unprecedented uncertainty'
WKHS Workhorse Group
$7.41 /

-0.78 (-9.52%)

09/22/21 Cowen
Workhorse Group price target lowered to $7.50 from $8.50 at Cowen
08/10/21 DA Davidson
Workhorse Group initiated with a Neutral at DA Davidson
08/10/21 B. Riley
Workhorse Group price target lowered to $14 from $16 at B. Riley
08/09/21 BTIG
BTIG lowers Workhorse Group target to $18 following Q2 results
INCY Incyte
$69.58 /

-6.45 (-8.48%)

09/09/21 Benchmark
Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
09/01/21 Cowen
Odds of Incyte drug exclusion from class warning 'largely unchanged,' says Cowen
07/20/21 Benchmark
Incyte upgraded to Buy from Hold at Benchmark
GIS General Mills
$59.94 /

+1.925 (+3.32%)

09/22/21 Piper Sandler
General Mills well-positioned in tough environment, says Piper Sandler
09/21/21
Fly Intel: Top five analyst downgrades
09/21/21 Morgan Stanley
General Mills downgraded to Underweight from Equal Weight at Morgan Stanley
09/13/21
Fly Intel: Top five analyst downgrades
INNV InnovAge
$8.81 /

-2.7 (-23.46%)

09/22/21 William Blair
InnovAge downgraded to Market Perform from Outperform at William Blair
09/22/21 Piper Sandler
InnovAge price target lowered to $20 from $31 at Piper Sandler
09/09/21 Cowen
InnovAge initiated with a Market Perform at Cowen
08/12/21 Barclays
InnovAge assumed at Overweight from Equal Weight at Barclays
BDSI BioDelivery Sciences
$3.50 /

-0.52 (-12.94%)

05/06/21 Roth Capital
BioDelivery Sciences price target lowered to $6.25 from $7 at Roth Capital
03/11/21 H.C. Wainwright
BioDelivery Sciences price target lowered to $5.50 from $7 at H.C. Wainwright
ADBE Adobe
$626.47 /

-19.94 (-3.08%)

09/22/21 Oppenheimer
Adobe price target raised to $680 from $600 at Oppenheimer
09/22/21 JPMorgan
Adobe price target raised to $680 from $660 at JPMorgan
09/22/21 Stifel
Adobe price target raised to $750 from $725 at Stifel
09/22/21 BMO Capital
Adobe price target lowered to $720 from $730 at BMO Capital
SFIX Stitch Fix
$41.04 /

+5.59 (+15.77%)

09/22/21 MKM Partners
MKM Partners warns that FY22 will not be inflection year for Stitch Fix
09/22/21 Canaccord
Stitch Fix price target lowered to $65 from $76 at Canaccord
09/22/21 KeyBanc
Stitch Fix price target lowered to $70 from $75 at KeyBanc
09/22/21 Stifel
Stitch Fix price target lowered to $46 from $70 at Stifel
WKHS Workhorse Group
$7.41 /

-0.78 (-9.52%)

TECK Teck Resources
$24.69 /

+1.51 (+6.51%)

SPWR SunPower
$22.26 /

+1.18 (+5.60%)

SOFI SoFi Technologies
$16.84 /

+1.685 (+11.12%)

SFIX Stitch Fix
$41.04 /

+5.59 (+15.77%)

PFE Pfizer
$43.95 /

+0.04 (+0.09%)

MCD McDonald's
$243.15 /

+2.57 (+1.07%)

INNV InnovAge
$8.81 /

-2.7 (-23.46%)

INCY Incyte
$69.58 /

-6.45 (-8.48%)

HOOD Robinhood
$46.90 /

+4.57 (+10.80%)

GOTU Gaotu Techedu
$3.09 /

+0.65 (+26.64%)

GIS General Mills
$59.94 /

+1.925 (+3.32%)

GILD Gilead
$71.38 /

-0.35 (-0.49%)

GE General Electric
$98.55 /

+1.68 (+1.73%)

FGEN FibroGen
$10.19 /

-1.045 (-9.31%)

FDX FedEx
$229.05 /

-23.04 (-9.14%)

DVAX Dynavax
$18.76 /

+3.91 (+26.33%)

BNTX BioNTech
$339.40 /

-2.11 (-0.62%)

BIIB Biogen
$289.26 /

-6.515 (-2.20%)

BDSI BioDelivery Sciences
$3.50 /

-0.52 (-12.94%)

AMZN Amazon.com
$3,380.08 /

+33.19 (+0.99%)

AMBA Ambarella
$164.22 /

+15.24 (+10.23%)

ADBE Adobe
$626.47 /

-19.94 (-3.08%)

AAPL Apple
$145.80 /

+2.39 (+1.67%)

  • 29
    Jul
  • 23
    Jul
  • 04
    Mar
WKHS Workhorse Group
$7.41 /

-0.78 (-9.52%)

TECK Teck Resources
$24.69 /

+1.51 (+6.51%)

SPWR SunPower
$22.26 /

+1.18 (+5.60%)

SOFI SoFi Technologies
$16.84 /

+1.685 (+11.12%)

SFIX Stitch Fix
$41.04 /

+5.59 (+15.77%)

PFE Pfizer
$43.95 /

+0.04 (+0.09%)

MCD McDonald's
$243.15 /

+2.57 (+1.07%)

INNV InnovAge
$8.81 /

-2.7 (-23.46%)

INCY Incyte
$69.58 /

-6.45 (-8.48%)

HOOD Robinhood
$46.90 /

+4.57 (+10.80%)

GOTU Gaotu Techedu
$3.09 /

+0.65 (+26.64%)

GIS General Mills
$59.94 /

+1.925 (+3.32%)

GILD Gilead
$71.38 /

-0.35 (-0.49%)

GE General Electric
$98.55 /

+1.68 (+1.73%)

FDX FedEx
$229.05 /

-23.04 (-9.14%)

ECIFF EDF
$11.50 /

+ (+0.00%)

BNTX BioNTech
$339.40 /

-2.11 (-0.62%)

BIIB Biogen
$289.26 /

-6.515 (-2.20%)

AMZN Amazon.com
$3,380.08 /

+33.19 (+0.99%)

ADBE Adobe
$626.47 /

-19.94 (-3.08%)

AAPL Apple
$145.80 /

+2.39 (+1.67%)

XPOF Xponential Fitness
$11.17 /

+0.875 (+8.50%)

WKHS Workhorse Group
$7.41 /

-0.78 (-9.52%)

TECK Teck Resources
$24.69 /

+1.51 (+6.51%)

SPWR SunPower
$22.26 /

+1.18 (+5.60%)

SOFI SoFi Technologies
$16.84 /

+1.685 (+11.12%)

SFIX Stitch Fix
$41.04 /

+5.59 (+15.77%)

PFE Pfizer
$43.95 /

+0.04 (+0.09%)

MCD McDonald's
$243.15 /

+2.57 (+1.07%)

INCY Incyte
$69.58 /

-6.45 (-8.48%)

HOOD Robinhood
$46.90 /

+4.57 (+10.80%)

GOTU Gaotu Techedu
$3.09 /

+0.65 (+26.64%)

GIS General Mills
$59.94 /

+1.925 (+3.32%)

GILD Gilead
$71.38 /

-0.35 (-0.49%)

GE General Electric
$98.55 /

+1.68 (+1.73%)

FGEN FibroGen
$10.19 /

-1.045 (-9.31%)

FDX FedEx
$229.05 /

-23.04 (-9.14%)

DVAX Dynavax
$18.76 /

+3.91 (+26.33%)

BNTX BioNTech
$339.40 /

-2.11 (-0.62%)

BIIB Biogen
$289.26 /

-6.515 (-2.20%)

AMZN Amazon.com
$3,380.08 /

+33.19 (+0.99%)

AMBA Ambarella
$164.22 /

+15.24 (+10.23%)

ADBE Adobe
$626.47 /

-19.94 (-3.08%)

AAPL Apple
$145.80 /

+2.39 (+1.67%)

WKHS Workhorse Group
$7.41 /

-0.78 (-9.52%)

TECK Teck Resources
$24.69 /

+1.51 (+6.51%)

SPWR SunPower
$22.26 /

+1.18 (+5.60%)

SOFI SoFi Technologies
$16.84 /

+1.685 (+11.12%)

SFIX Stitch Fix
$41.04 /

+5.59 (+15.77%)

PFE Pfizer
$43.95 /

+0.04 (+0.09%)

MCD McDonald's
$243.15 /

+2.57 (+1.07%)

INCY Incyte
$69.58 /

-6.45 (-8.48%)

HOOD Robinhood
$46.90 /

+4.57 (+10.80%)

GOTU Gaotu Techedu
$3.09 /

+0.65 (+26.64%)

GIS General Mills
$59.94 /

+1.925 (+3.32%)

GILD Gilead
$71.38 /

-0.35 (-0.49%)

GE General Electric
$98.55 /

+1.68 (+1.73%)

FDX FedEx
$229.05 /

-23.04 (-9.14%)

DVAX Dynavax
$18.76 /

+3.91 (+26.33%)

BIIB Biogen
$289.26 /

-6.515 (-2.20%)

AMZN Amazon.com
$3,380.08 /

+33.19 (+0.99%)

AMBA Ambarella
$164.22 /

+15.24 (+10.23%)

ADBE Adobe
$626.47 /

-19.94 (-3.08%)

AAPL Apple
$145.80 /

+2.39 (+1.67%)

AAPL Apple
$145.80 /

+2.39 (+1.67%)

Initiation
Biogen initiated with a Buy at Needham » 16:21
09/22/21
09/22
16:21
09/22/21
16:21
BIIB

Biogen

$289.26 /

-6.515 (-2.20%)

Needham analyst Ami Fadia…

Needham analyst Ami Fadia initiated coverage of Biogen with a Buy rating and $400 price target. The analyst said that Aduhelm's potential and pipeline appear "underappreciated," adding that while the treatment's inintial ramp may miss consensuss, her survey suggests its sales can grow to over $6B worldwide in 2026, versus the consensus of $6.4B.

ShowHide Related Items >><<
BIIB Biogen
$289.26 /

-6.515 (-2.20%)

BIIB Biogen
$289.26 /

-6.515 (-2.20%)

09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
09/20/21 Piper Sandler
Neurologist survey shows Aduhelm 'rebounded sharply,' says Piper Sandler
09/16/21 UBS
Biogen price target lowered to $442 from $475 at UBS
09/15/21 BofA
Biogen price target lowered to $360 from $400 at BofA
BIIB Biogen
$289.26 /

-6.515 (-2.20%)

BIIB Biogen
$289.26 /

-6.515 (-2.20%)

BIIB Biogen
$289.26 /

-6.515 (-2.20%)

BIIB Biogen
$289.26 /

-6.515 (-2.20%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 13:12
09/22/21
09/22
13:12
09/22/21
13:12
FDX

FedEx

$231.28 /

-20.81 (-8.25%)

, ADBE

Adobe

$625.23 /

-21.18 (-3.28%)

, GILD

Gilead

$71.77 /

+0.04 (+0.06%)

, PFE

Pfizer

$44.30 /

+0.39 (+0.89%)

, BNTX

BioNTech

$342.26 /

+0.75 (+0.22%)

, SFIX

Stitch Fix

$40.34 /

+4.89 (+13.79%)

, AMZN

Amazon.com

$3,367.50 /

+20.61 (+0.62%)

, AAPL

Apple

$145.21 /

+1.8 (+1.26%)

, GE

General Electric

$98.50 /

+1.63 (+1.68%)

, ECIFF

EDF

$11.50 /

+ (+0.00%)

, BIIB

Biogen

$290.49 /

-5.28 (-1.79%)

, MCD

McDonald's

$244.30 /

+3.72 (+1.55%)

, DVAX

Dynavax

$20.52 /

+5.67 (+38.18%)

, TECK

Teck Resources

$24.63 /

+1.45 (+6.26%)

, GOTU

Gaotu Techedu

$3.16 /

+0.72 (+29.51%)

, WKHS

Workhorse Group

$7.43 /

-0.765 (-9.34%)

, INCY

Incyte

$70.73 /

-5.3 (-6.97%)

, GIS

General Mills

$60.61 /

+2.595 (+4.47%)

, INNV

InnovAge

$8.86 /

-2.65 (-23.02%)

, BDSI

BioDelivery Sciences

$3.58 /

-0.44 (-10.95%)

, GDEV

Nexters

$8.30 /

-0.6 (-6.74%)

, AKTX

Akari Therapeutics

$1.71 /

-0.05 (-2.84%)

, XPOF

Xponential Fitness

$11.33 /

+1.035 (+10.05%)

, SOFI

SoFi Technologies

$16.88 /

+1.73 (+11.42%)

, SPWR

SunPower

$22.26 /

+1.18 (+5.60%)

, AMBA

Ambarella

$162.27 /

+13.29 (+8.92%)

, FGEN

FibroGen

$10.17 /

-1.06 (-9.44%)

Get caught up quickly on…

ShowHide Related Items >><<
XPOF Xponential Fitness
$11.33 /

+1.035 (+10.05%)

WKHS Workhorse Group
$7.43 /

-0.765 (-9.34%)

TECK Teck Resources
$24.63 /

+1.45 (+6.26%)

SPWR SunPower
$22.26 /

+1.18 (+5.60%)

SOFI SoFi Technologies
$16.88 /

+1.73 (+11.42%)

SFIX Stitch Fix
$40.34 /

+4.89 (+13.79%)

PFE Pfizer
$44.30 /

+0.39 (+0.89%)

MCD McDonald's
$244.30 /

+3.72 (+1.55%)

INNV InnovAge
$8.86 /

-2.65 (-23.02%)

INCY Incyte
$70.73 /

-5.3 (-6.97%)

GOTU Gaotu Techedu
$3.16 /

+0.72 (+29.51%)

GIS General Mills
$60.61 /

+2.595 (+4.47%)

GILD Gilead
$71.77 /

+0.04 (+0.06%)

GE General Electric
$98.50 /

+1.63 (+1.68%)

GDEV Nexters
$8.30 /

-0.6 (-6.74%)

FGEN FibroGen
$10.17 /

-1.06 (-9.44%)

FDX FedEx
$231.28 /

-20.81 (-8.25%)

DVAX Dynavax
$20.52 /

+5.67 (+38.18%)

BNTX BioNTech
$342.26 /

+0.75 (+0.22%)

BIIB Biogen
$290.49 /

-5.28 (-1.79%)

BDSI BioDelivery Sciences
$3.58 /

-0.44 (-10.95%)

AMZN Amazon.com
$3,367.50 /

+20.61 (+0.62%)

AMBA Ambarella
$162.27 /

+13.29 (+8.92%)

AKTX Akari Therapeutics
$1.71 /

-0.05 (-2.84%)

ADBE Adobe
$625.23 /

-21.18 (-3.28%)

AAPL Apple
$145.21 /

+1.8 (+1.26%)

FDX FedEx
$231.28 /

-20.81 (-8.25%)

09/22/21
Fly Intel: Top five analyst downgrades
09/22/21 Wells Fargo
FedEx price target lowered to $314 from $351 at Wells Fargo
09/22/21 Stephens
FedEx price target lowered to $330 from $360 at Stephens
09/22/21 KeyBanc
FedEx price target lowered to $325 from $350 at KeyBanc
ADBE Adobe
$625.23 /

-21.18 (-3.28%)

09/22/21 Oppenheimer
Adobe price target raised to $680 from $600 at Oppenheimer
09/22/21 JPMorgan
Adobe price target raised to $680 from $660 at JPMorgan
09/22/21 Stifel
Adobe price target raised to $750 from $725 at Stifel
09/22/21 BMO Capital
Adobe price target lowered to $720 from $730 at BMO Capital
GILD Gilead
$71.77 /

+0.04 (+0.06%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
PFE Pfizer
$44.30 /

+0.39 (+0.89%)

09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
BNTX BioNTech
$342.26 /

+0.75 (+0.22%)

08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
08/20/21 Canaccord
BioNTech price target raised to $450 from $240 at Canaccord
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
SFIX Stitch Fix
$40.34 /

+4.89 (+13.79%)

09/22/21 MKM Partners
MKM Partners warns that FY22 will not be inflection year for Stitch Fix
09/22/21 Canaccord
Stitch Fix price target lowered to $65 from $76 at Canaccord
09/22/21 KeyBanc
Stitch Fix price target lowered to $70 from $75 at KeyBanc
09/22/21 Stifel
Stitch Fix price target lowered to $46 from $70 at Stifel
AMZN Amazon.com
$3,367.50 /

+20.61 (+0.62%)

09/14/21 Evercore ISI
Amazon price target raised to $4,700 from $4,200 at Evercore ISI
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Goldman Sachs
Amazon.com initiated with a Buy at Goldman Sachs
09/10/21 BofA
Affirm price target raised to $119 from $82 at BofA
AAPL Apple
$145.21 /

+1.8 (+1.26%)

09/22/21 Tigress Financial
Apple price target raised to $198 from $182 at Tigress Financial
09/21/21 BofA
BofA says nationalist sentiment resurgence in China could hurt iPhone sales
09/21/21 Credit Suisse
Apple iPhone 13 initial waits extended versus 12 cycle, says Credit Suisse
09/17/21 Jefferies
Snap Q3 revenue estimates too low, says Jefferies
GE General Electric
$98.50 /

+1.63 (+1.68%)

09/03/21 JPMorgan
Los Angeles vote shows 'secular decline' risk of GE Power, says JPMorgan
08/11/21 Citi
GE price target adjusted to $136 at Citi to account for reverse split
08/11/21 JPMorgan
GE industrial FCF a 'construct' that is 'detached from reality,' says JPMorgan
07/14/21 Deutsche Bank
General Electric price target lowered to $14 from $15 at Deutsche Bank
ECIFF EDF
$11.50 /

+ (+0.00%)

BIIB Biogen
$290.49 /

-5.28 (-1.79%)

09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
09/20/21 Piper Sandler
Neurologist survey shows Aduhelm 'rebounded sharply,' says Piper Sandler
09/16/21 UBS
Biogen price target lowered to $442 from $475 at UBS
09/15/21 BofA
Biogen price target lowered to $360 from $400 at BofA
MCD McDonald's
$244.30 /

+3.72 (+1.55%)

07/29/21 RBC Capital
McDonald's price target raised to $268 from $263 at RBC Capital
07/29/21 Truist
McDonald's price target raised to $266 from $255 at Truist
07/29/21 Wedbush
McDonald's price target raised to $270 from $265 at Wedbush
07/29/21 Stephens
McDonald's price target raised to $260 from $245 at Stephens
DVAX Dynavax
$20.52 /

+5.67 (+38.18%)

08/31/21 H.C. Wainwright
Dynavax price target raised to $23 from $20 at H.C. Wainwright
08/05/21 Goldman Sachs
Dynavax initiated with a Buy at Goldman Sachs
08/05/21 H.C. Wainwright
Dynavax price target raised to $20 from $16 at H.C. Wainwright
02/08/21 Evercore ISI
Dynavax had 'big vaccine update week,' says Evercore ISI
TECK Teck Resources
$24.63 /

+1.45 (+6.26%)

09/22/21 Canaccord
Teck Resources price target raised to C$31 from C$28 at Canaccord
09/22/21 CIBC
Teck Resources price target raised to C$35.50 from C$34 at CIBC
09/22/21 Raymond James
Teck Resources price target raised to C$39 from C$37 at Raymond James
09/22/21 Scotiabank
Teck Resources price target lowered to C$3.21 from C$3.35 at Scotiabank
GOTU Gaotu Techedu
$3.16 /

+0.72 (+29.51%)

07/27/21 Deutsche Bank
Gaotu Techedu price target lowered to $3 from $97 at Deutsche Bank
07/26/21 CLSA
Gaotu Techedu downgraded to Sell from Underperform at CLSA
07/25/21 Goldman Sachs
Gaotu Techedu downgraded to Sell from Neutral at Goldman Sachs
07/23/21 JPMorgan
JPMorgan downgrades China education stock trio on 'unprecedented uncertainty'
WKHS Workhorse Group
$7.43 /

-0.765 (-9.34%)

08/10/21 DA Davidson
Workhorse Group initiated with a Neutral at DA Davidson
08/10/21 B. Riley
Workhorse Group price target lowered to $14 from $16 at B. Riley
08/09/21 BTIG
BTIG lowers Workhorse Group target to $18 following Q2 results
07/29/21 B. Riley
Workhorse Group's new CEO Dauch a 'nice fit,' says B. Riley
INCY Incyte
$70.73 /

-5.3 (-6.97%)

09/09/21 Benchmark
Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
09/01/21 Cowen
Odds of Incyte drug exclusion from class warning 'largely unchanged,' says Cowen
07/20/21 Benchmark
Incyte upgraded to Buy from Hold at Benchmark
GIS General Mills
$60.61 /

+2.595 (+4.47%)

09/21/21
Fly Intel: Top five analyst downgrades
09/21/21 Morgan Stanley
General Mills downgraded to Underweight from Equal Weight at Morgan Stanley
09/13/21
Fly Intel: Top five analyst downgrades
09/13/21 Credit Suisse
General Mills downgraded to Neutral from Outperform at Credit Suisse
INNV InnovAge
$8.86 /

-2.65 (-23.02%)

09/22/21 William Blair
InnovAge downgraded to Market Perform from Outperform at William Blair
09/22/21 Piper Sandler
InnovAge price target lowered to $20 from $31 at Piper Sandler
09/09/21 Cowen
InnovAge initiated with a Market Perform at Cowen
08/12/21 Barclays
InnovAge assumed at Overweight from Equal Weight at Barclays
BDSI BioDelivery Sciences
$3.58 /

-0.44 (-10.95%)

05/06/21 Roth Capital
BioDelivery Sciences price target lowered to $6.25 from $7 at Roth Capital
03/11/21 H.C. Wainwright
BioDelivery Sciences price target lowered to $5.50 from $7 at H.C. Wainwright
GDEV Nexters
$8.30 /

-0.6 (-6.74%)

AKTX Akari Therapeutics
$1.71 /

-0.05 (-2.84%)

XPOF Xponential Fitness
$11.33 /

+1.035 (+10.05%)

09/22/21
Fly Intel: Top five analyst upgrades
09/22/21 Raymond James
Xponential Fitness double upgraded to Strong Buy at Raymond James
09/22/21 Raymond James
Xponential Fitness upgraded to Strong Buy from Market Perform at Raymond James
08/17/21 Guggenheim
Xponential Fitness initiated with Buy, $16 target at Guggenheim
SOFI SoFi Technologies
$16.88 /

+1.73 (+11.42%)

09/22/21
Fly Intel: Top five analyst initiations
09/22/21 Jefferies
SoFi Technologies initiated with a Buy at Jefferies
09/14/21 Mizuho
Mizuho starts SoFi with Buy amid 'powerful transition' to 'neo-bank'
09/14/21 Mizuho
SoFi Technologies initiated with a Buy at Mizuho
SPWR SunPower
$22.26 /

+1.18 (+5.60%)

09/22/21 Evercore ISI
Evercore starts SunPower at Outperform, sees 26% upside potential
09/22/21 Evercore ISI
SunPower initiated with an Outperform at Evercore ISI
07/15/21 Piper Sandler
SunPower price target lowered to $26 from $28 at Piper Sandler
AMBA Ambarella
$162.27 /

+13.29 (+8.92%)

09/22/21 KeyBanc
Ambarella upgraded to Overweight from Sector Weight at KeyBanc
09/02/21 Roth Capital
Ambarella price target raised to $170 from $130 at Roth Capital
09/01/21 Cowen
Ambarella price target raised to $150 from $140 at Cowen
FGEN FibroGen
$10.17 /

-1.06 (-9.44%)

09/22/21 Goldman Sachs
FibroGen downgraded to Sell from Neutral at Goldman Sachs
08/20/21 Raymond James
FibroGen upgraded to Market Perform from Underperform at Raymond James
08/20/21 Raymond James
FibroGen upgraded to Market Perform from Underperform at Raymond James
WKHS Workhorse Group
$7.43 /

-0.765 (-9.34%)

TECK Teck Resources
$24.63 /

+1.45 (+6.26%)

SPWR SunPower
$22.26 /

+1.18 (+5.60%)

SOFI SoFi Technologies
$16.88 /

+1.73 (+11.42%)

SFIX Stitch Fix
$40.34 /

+4.89 (+13.79%)

PFE Pfizer
$44.30 /

+0.39 (+0.89%)

MCD McDonald's
$244.30 /

+3.72 (+1.55%)

INNV InnovAge
$8.86 /

-2.65 (-23.02%)

INCY Incyte
$70.73 /

-5.3 (-6.97%)

GOTU Gaotu Techedu
$3.16 /

+0.72 (+29.51%)

GIS General Mills
$60.61 /

+2.595 (+4.47%)

GILD Gilead
$71.77 /

+0.04 (+0.06%)

GE General Electric
$98.50 /

+1.63 (+1.68%)

GDEV Nexters
$8.30 /

-0.6 (-6.74%)

FGEN FibroGen
$10.17 /

-1.06 (-9.44%)

FDX FedEx
$231.28 /

-20.81 (-8.25%)

DVAX Dynavax
$20.52 /

+5.67 (+38.18%)

BNTX BioNTech
$342.26 /

+0.75 (+0.22%)

BIIB Biogen
$290.49 /

-5.28 (-1.79%)

BDSI BioDelivery Sciences
$3.58 /

-0.44 (-10.95%)

AMZN Amazon.com
$3,367.50 /

+20.61 (+0.62%)

AMBA Ambarella
$162.27 /

+13.29 (+8.92%)

AKTX Akari Therapeutics
$1.71 /

-0.05 (-2.84%)

ADBE Adobe
$625.23 /

-21.18 (-3.28%)

AAPL Apple
$145.21 /

+1.8 (+1.26%)

  • 23
    Jul
  • 04
    Mar
WKHS Workhorse Group
$7.43 /

-0.765 (-9.34%)

TECK Teck Resources
$24.63 /

+1.45 (+6.26%)

SPWR SunPower
$22.26 /

+1.18 (+5.60%)

SOFI SoFi Technologies
$16.88 /

+1.73 (+11.42%)

SFIX Stitch Fix
$40.34 /

+4.89 (+13.79%)

PFE Pfizer
$44.30 /

+0.39 (+0.89%)

MCD McDonald's
$244.30 /

+3.72 (+1.55%)

INNV InnovAge
$8.86 /

-2.65 (-23.02%)

INCY Incyte
$70.73 /

-5.3 (-6.97%)

GOTU Gaotu Techedu
$3.16 /

+0.72 (+29.51%)

GIS General Mills
$60.61 /

+2.595 (+4.47%)

GILD Gilead
$71.77 /

+0.04 (+0.06%)

GE General Electric
$98.50 /

+1.63 (+1.68%)

FDX FedEx
$231.28 /

-20.81 (-8.25%)

BNTX BioNTech
$342.26 /

+0.75 (+0.22%)

BIIB Biogen
$290.49 /

-5.28 (-1.79%)

AMZN Amazon.com
$3,367.50 /

+20.61 (+0.62%)

ADBE Adobe
$625.23 /

-21.18 (-3.28%)

AAPL Apple
$145.21 /

+1.8 (+1.26%)

XPOF Xponential Fitness
$11.33 /

+1.035 (+10.05%)

WKHS Workhorse Group
$7.43 /

-0.765 (-9.34%)

TECK Teck Resources
$24.63 /

+1.45 (+6.26%)

SPWR SunPower
$22.26 /

+1.18 (+5.60%)

SOFI SoFi Technologies
$16.88 /

+1.73 (+11.42%)

SFIX Stitch Fix
$40.34 /

+4.89 (+13.79%)

PFE Pfizer
$44.30 /

+0.39 (+0.89%)

MCD McDonald's
$244.30 /

+3.72 (+1.55%)

INCY Incyte
$70.73 /

-5.3 (-6.97%)

GOTU Gaotu Techedu
$3.16 /

+0.72 (+29.51%)

GIS General Mills
$60.61 /

+2.595 (+4.47%)

GILD Gilead
$71.77 /

+0.04 (+0.06%)

GE General Electric
$98.50 /

+1.63 (+1.68%)

FGEN FibroGen
$10.17 /

-1.06 (-9.44%)

FDX FedEx
$231.28 /

-20.81 (-8.25%)

DVAX Dynavax
$20.52 /

+5.67 (+38.18%)

BNTX BioNTech
$342.26 /

+0.75 (+0.22%)

BIIB Biogen
$290.49 /

-5.28 (-1.79%)

AMZN Amazon.com
$3,367.50 /

+20.61 (+0.62%)

AMBA Ambarella
$162.27 /

+13.29 (+8.92%)

ADBE Adobe
$625.23 /

-21.18 (-3.28%)

AAPL Apple
$145.21 /

+1.8 (+1.26%)

WKHS Workhorse Group
$7.43 /

-0.765 (-9.34%)

TECK Teck Resources
$24.63 /

+1.45 (+6.26%)

SPWR SunPower
$22.26 /

+1.18 (+5.60%)

SOFI SoFi Technologies
$16.88 /

+1.73 (+11.42%)

SFIX Stitch Fix
$40.34 /

+4.89 (+13.79%)

PFE Pfizer
$44.30 /

+0.39 (+0.89%)

MCD McDonald's
$244.30 /

+3.72 (+1.55%)

INCY Incyte
$70.73 /

-5.3 (-6.97%)

GOTU Gaotu Techedu
$3.16 /

+0.72 (+29.51%)

GIS General Mills
$60.61 /

+2.595 (+4.47%)

GILD Gilead
$71.77 /

+0.04 (+0.06%)

GE General Electric
$98.50 /

+1.63 (+1.68%)

FDX FedEx
$231.28 /

-20.81 (-8.25%)

DVAX Dynavax
$20.52 /

+5.67 (+38.18%)

BIIB Biogen
$290.49 /

-5.28 (-1.79%)

AMZN Amazon.com
$3,367.50 /

+20.61 (+0.62%)

AMBA Ambarella
$162.27 /

+13.29 (+8.92%)

ADBE Adobe
$625.23 /

-21.18 (-3.28%)

AAPL Apple
$145.21 /

+1.8 (+1.26%)

AAPL Apple
$145.21 /

+1.8 (+1.26%)

On The Fly
Incyte sinks after eczema cream approval comes with boxed warnings » 10:56
09/22/21
09/22
10:56
09/22/21
10:56
INCY

Incyte

$71.30 /

-4.73 (-6.22%)

, PFE

Pfizer

$44.15 /

+0.24 (+0.55%)

, LLY

Eli Lilly

$229.35 /

-0.835 (-0.36%)

, ABBV

AbbVie

$107.24 /

+0.09 (+0.08%)

Shares of Incyte (INCY)…

ShowHide Related Items >><<
PFE Pfizer
$44.15 /

+0.24 (+0.55%)

LLY Eli Lilly
$229.35 /

-0.835 (-0.36%)

INCY Incyte
$71.30 /

-4.73 (-6.22%)

ABBV AbbVie
$107.24 /

+0.09 (+0.08%)

INCY Incyte
$71.30 /

-4.73 (-6.22%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/09/21 Benchmark
Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
09/01/21 Cowen
Odds of Incyte drug exclusion from class warning 'largely unchanged,' says Cowen
07/20/21 Benchmark
Incyte upgraded to Buy from Hold at Benchmark
PFE Pfizer
$44.15 /

+0.24 (+0.55%)

09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
LLY Eli Lilly
$229.35 /

-0.835 (-0.36%)

09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
ABBV AbbVie
$107.24 /

+0.09 (+0.08%)

09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
PFE Pfizer
$44.15 /

+0.24 (+0.55%)

LLY Eli Lilly
$229.35 /

-0.835 (-0.36%)

INCY Incyte
$71.30 /

-4.73 (-6.22%)

ABBV AbbVie
$107.24 /

+0.09 (+0.08%)

PFE Pfizer
$44.15 /

+0.24 (+0.55%)

LLY Eli Lilly
$229.35 /

-0.835 (-0.36%)

INCY Incyte
$71.30 /

-4.73 (-6.22%)

ABBV AbbVie
$107.24 /

+0.09 (+0.08%)

PFE Pfizer
$44.15 /

+0.24 (+0.55%)

LLY Eli Lilly
$229.35 /

-0.835 (-0.36%)

INCY Incyte
$71.30 /

-4.73 (-6.22%)

ABBV AbbVie
$107.24 /

+0.09 (+0.08%)

PFE Pfizer
$44.15 /

+0.24 (+0.55%)

LLY Eli Lilly
$229.35 /

-0.835 (-0.36%)

INCY Incyte
$71.30 /

-4.73 (-6.22%)

ABBV AbbVie
$107.24 /

+0.09 (+0.08%)

Hot Stocks
Biogen falls after STAT says just over 100 patients on Aduhelm as of Sept. 11  07:44
09/22/21
09/22
07:44
09/22/21
07:44
BIIB

Biogen

$295.83 /

-2.7 (-0.90%)

 
ShowHide Related Items >><<
BIIB Biogen
$295.83 /

-2.7 (-0.90%)

BIIB Biogen
$295.83 /

-2.7 (-0.90%)

09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
09/20/21 Piper Sandler
Neurologist survey shows Aduhelm 'rebounded sharply,' says Piper Sandler
09/16/21 UBS
Biogen price target lowered to $442 from $475 at UBS
09/15/21 BofA
Biogen price target lowered to $360 from $400 at BofA
BIIB Biogen
$295.83 /

-2.7 (-0.90%)

BIIB Biogen
$295.83 /

-2.7 (-0.90%)

BIIB Biogen
$295.83 /

-2.7 (-0.90%)

BIIB Biogen
$295.83 /

-2.7 (-0.90%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.